|
MITOCHONDRIAL GENOME DISORDERS |
|
MITO-WGA
|
Whole Mitochondrial Genome Analysis with Haplotyping |
|
MITO-PT-DEL |
mtDNA Disorder Point Mutation and Deletion Assay |
|
MITO-DEL |
mtDNA Deletion Assay (CPEO, KSS, Maternally Inherited Deafness,
Pearson’s Syndrome) |
|
MITO-COPY |
Mitochondrial Copy Number |
|
CYTB |
Cytochrome b (MTCYB) |
|
RCD |
Reversible Cox Deficiency |
|
DFNS |
Deafness, Aminoglycoside-Induced Nonsyndromic Deafness |
|
LHON |
Leber’s Hereditary Optic Neuropathy |
|
MELAS |
Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like
Episodes |
|
MERRF |
Myoclonus Epilepsy with Ragged Red Fibers |
|
NARP |
Neurogenic Weakness, Ataxia, Retinitis Pigmentosa and Leigh’s Syndrome |
|
NUCLEAR MITOCHONDRIAL DISORDERS |
|
NUCLEAR-MITOME |
Comprehensive Sequence Analysis of >400 Nuclear Mitochondrial Genes
|
|
POLG |
POLG-Related Disorders: PEO, Alper’s Syndrome, Parkinsonism, Juvenile
SCAE and SANDO |
|
POLG2 |
POLG2-Related Disorders |
|
SLC25A4 |
Autosomal Dominant Progressive External Ophthalmoplegia |
|
C10orf2 |
Autosomal Dominant Progressive External Ophthalmoplegia (TWINKLE or
PEO1) |
|
AD-PEO PANEL |
POLG, SLC25A4, C10orf2 |
|
TYMP |
MNGIE
Syndrome (Mito-Neurogastrointestinal Encephalomyopathy) |
|
COMPLEX I PANEL |
NDUFA1, NDUFA2, NDUFA7, NDUFAF2, NDUFAF3, NDUFAF4, NDUFS3, NDUFS4,
NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2 |
|
BCS1L |
Complex III Deficiency – Bjornstad Syndrome, GRACILE Syndrome
|
|
COMPLEX IV PANEL |
Complex IV Deficiency Panel – (COX10, SCO1, SCO2, SURF1)
|
|
DGUOK |
mtDNA Depletion
Syndrome – Hepatocerebral Form |
|
MPV17 |
mtDNA Depletion Syndrome – Infantile Hepatic Form
|
|
TK2
|
mtDNA Depletion
Syndrome – Myopathic Form |
|
MITO-DEP |
Mitochondrial Depletion Syndrome, Hepatocerebral Form, Panel (MPV17,
DGUOK, POLG1) |
|
MITO-DEP/DEL |
Mitochondrial
Depletion Syndrome and Multiple Deletion Panel (POLG1, TK2, DGUOK) |
|
EPILEPSY AND SEIZURE-RELATED
DISORDERS |
|
FSP |
Febrile
Seizure Panel (SCN1A, SCN1B, SCN2A, GABRD, GABRG2 and Large Del/Dup
analysis of SCN1A) |
|
FFSP |
Female
Febrile Seizure Panel (Febrile Seizure panel plus sequencing of PCDH19) |
|
SCN1A |
Sequencing
- GEFS+, Dravet Syndrome |
|
SCN1A-DEL/DUP |
Large
Scale Deletion/Duplication Detection |
|
SCN1A-REF |
SCN1A
Sequencing reflexes to SCN1A Deletion/Duplication Analysis |
|
SCN1A-COM |
SCN1A
and SCN1A Deletion/Duplication run in parallel |
|
SCN1B |
GEFS+, Dravet Syndrome |
|
SCN2A |
GEFS+,
Dravet Syndrome |
|
GABRD |
GEFS+, Dravet Syndrome |
|
GABRG2 |
GEFS+,
Dravet Syndrome |
|
PCDH19 |
Epilepsy
limited to females with mental retardation |
|
CHROMOSOMAL ANALYSIS |
|
KARYO |
Karyotyping |
|
CMA-180K |
Microarray
Chip-180K |
|
OTHER TESTS |
|
CPT2 |
CPT2 Deficiency |
|
OPA1 |
Optic Atrophy
Type 1 |
|
VLCAD
|
VLCAD Deficiency |
|
CDKL5 |
Autism, Rett
Syndrome |
|
MECP2 |
Sequencing |
|
MECP2-DEL/DUP |
Large
Scale Deletion/Duplication Analysis |
|
MECP2-REF |
MECP2 Sequencing reflexes to MECP2 Deletion/Duplication
Analysis |
|
MECP2-COM |
Sequencing and Deletion/Duplication run in parallel |
|
BDNF |
Brain-Derived Neurotrophic Factor (BDNF) Epilepsy |
|
PTEN |
Autism |
|
UBE3A
|
Angelman Syndrome |
|
FRAGX-M
|
Fragile X
Syndrome (FMR1; Male) |
|
FRAGX-F
|
Fragile X Syndrome (FMR1; Female)
|
|
NOONAN |
Noonan
Syndrome (PTPN11, RAF1, SOS1, KRAS) |
|
LPIN1
|
Autosomal Recessive Recurrent Myoglobinuria
|
|
PWS |
Prader-Willi Syndrome |
|
ONCOLOGY |
|
KIT |
Exons 8 through 17 |
|
KIT 1 |
Tier 1 (Exons
8, 9, 11, 13, 17) |
|
KIT 2 |
Tier 2 (Exons 10, 12, 14, 15, 16) |
|
KRAS |
KRAS |
|
PIK3CA |
Exons 9 and 20 |
|
P53 |
P53 |
|
PTEN |
PTEN |
|
VHL
|
Von Hippel-Lindau Cancer Syndrome |